Endothelial dysfunction in obesity: Etiological role in atherosclerosis

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 14, Issue 5, 2007, Pages 365-369

  Meyers, Melissa R ^a   Gokce, Noyan ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

Adipokines; Atherosclerosis; Endothelium; Obesity; Vasculature

Indexed keywords

ADIPOCYTOKINE; INSULIN;

ADIPOSE TISSUE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; DIABETES MELLITUS; DISEASE COURSE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; RISK REDUCTION; VASCULAR ENDOTHELIUM; WEIGHT REDUCTION;

ADIPOKINES; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; HOMEOSTASIS; HUMANS; HYPERLIPIDEMIAS; INFLAMMATION; INSULIN RESISTANCE; OBESITY; OXIDATIVE STRESS; RISK FACTORS; RISK REDUCTION BEHAVIOR; VASCULAR DISEASES; WEIGHT LOSS;

EID: 34548441102     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e3282be90a8     Document Type: Review

References (58)

1. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction - testing and clinical relevance. Circulation 2007; 115:1285-1295. An excellent review of endothelial dysfunction in clinical disease.
2. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323:27-36.
3. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333:664-666.
4. Widlansky ME, Gokce N, Keaney JF Jr. Vita: the clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42:1149-1160.
5. Steinberg HO, Chaker H, Leaming R, et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97:2601-2610.
6. Gielen S, Hambrecht R. The childhood obesity epidemic - impact on endothelial function. Circulation 2004; 109:1911-1913.
7. Gokce N, Keaney JF Jr, Menzoian JO, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function. Circulation 2002; 105:1567-1572.
8. Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106:653-658.
9. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101:1899-1906.
10. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39:257-265.
11. Kullo IJ, Malik AR. Arterial ultrasonography and tonometry as adjuncts to cardiovascular risk stratification. J Am Coll Cardiol 2007; 49:1413-1426.
12. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291:2847-2850.
13. McTigue K, Larson JC, Valoski A, et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 2006; 296:79-86.
14. Freedman DS, Khan LK, Serdula MK, et al. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002; 288:1758-1761.
15. Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005; 352:1138-1145.
16. Whincup PH, Gilg JA, Donald AE, et al. Arterial distensibility in adolescents - the influence of adiposity, the metabolic syndrome, and classic risk factors. Circulation 2005; 112:1789-1797.
17. Meyer AA, Kundt G, Steiner M, et al. Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors. Pediatrics 2006; 117:1560-1567.
18. McGill HC Jr, McMahan CA, Herderick EE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002; 105:2712-2718.
19. Benjamin EJ, Larson MG, Keyes MJ, et al. Clinical correlates and heritability of flow-mediated dilation in the community - the Framingham Heart Study. Circulation 2004; 109:613-619.
20. Pulerwitz T, Grahame-Clarke C, Rodriguez CJ, et al. Association of increased body mass index and impaired endothelial function among Hispanic women. Am J Cardiol 2006; 97:68-70.
21. Williams IL, Chowienczyk PJ, Wheatcroft SB, et al. Effect of fat distribution on endothelial-dependent and endothelial-independent vasodilatation in healthy humans. Diabetes Obes Metab 2006; 8:296-301.
22. Brook RD, Bard RL, Rubenfire M, et al. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 2001; 88:1264-1269.
23. Arcaro G, Zamboni M, Rossi L, et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord 1999; 23:936-942.
24. Wildman RP, Mackey RH, Bostom A, et al. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension 2003; 42:468-473.
25. Avogaro A, de Kreutzenberg SV. Mechanisms of endothelial dysfunction in obesity. Clin Chim Acta 2005; 360:9-26.
26. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135-1143.
27. O'Brien KD, Allen MD, McDonald TO, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993; 92:945-951.
28. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104:365-372.
29. Klein S, Burke LE, Bray GA, et al. Clinical implications of obesity with specific focus on cardiovascular disease - a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism - endorsed by the American College of Cardiology Foundation. Circulation 2004; 110:2952-2967.
30. Ghanim H, Aljada A, Hofmeyer D, et al. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004; 110:1564-1571.
31. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116:1793-1801. A seminal review of the potential mechanisms of inflammatory activity in fat tissue in relation to systemic disease.
32. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6:772-783.
33. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89:2548-2556.
34. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112:1785-1788.
35. Weisberg SP, Hunter D, Huber R, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006; 116:115-124.
36. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96:939-949.
37. Rask-Madsen C, King GL. Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab 2007; 3:46-56. A focused review of mechanisms of vascular disease in insulin-resistant states.
38. Han SH, Quon MJ, Kim J, Koh KK. Adiponectin and cardiovascular disease - response to therapeutic interventions. J Am Coll Cardiol 2007; 49:531-538.
39. Ouchi N, Ohishi M, Kihara S, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003; 42:231-234.
40. Wolk R, Berger P, Lennon RJ, et al. Association between plasma adiponectin levels and unstable coronary syndromes. Eur Heart J 2007; 28:292-298.
41. Vohl MC, Sladek R, Robitaille J, et al. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obesity Res 2004; 12:1217-1222.
42. Henrichot E, Juge-Aubry CE, Pernin AS, et al. Production of chemokines by perivascular adipose tissue - a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 2005; 25:2594-2599.
43. Mazurek T, Zhang LF, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108:2460-2466.
44. Iacobellis G, Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab 2005; 90:6300-6302.
45. Silver AE, Beske SD, Christou DD, et al. Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation 2007; 115:627-637. A clinical study utilizing a highly novel technique of examining endothelial cell characteristics in human subjects.
46. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114:1752-1761.
47. Keaney JF Jr, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003; 23:434-439.
48. Sciacqua A, Candigliota M, Ceravolo R, et al. Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care 2003; 26:1673-1678.
49. Hamdy O, Ledbury S, Mullooly C, et al. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 2003; 26:2119-2125.
50. Raitakari M, Ilvonen T, Ahotupa M, et al. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol 2004; 24:124-128.
51. Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105:804-809.
52. Gokce N, Vita JA, McDonnell M, et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol 2005; 95:266-268.
53. Woo KS, Chook P, Yu CW, et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004; 109:1981-1986.
54. Wildman RP, Farhat GN, Patel AS, et al. Weight change is associated with change in arterial stiffness among healthy young adults. Hypertension 2005; 45:187-192.
55. Wunsch R, de Sousa G, Toschke AM, Reinehr T. Intima-media thickness in obese children before and after weight loss. Pediatrics 2006; 118:2334-2340.
56. Engeli S, Bohnke J, Gorzelniak K, et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005; 45:356-362.
57. Cancello R, Henegar C, Viguerie N, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery induced weight loss. Diabetes 2005; 54:2277-2286.
58. Clement K, Viguerie N, Poitou C, et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004; 18:1657-1669.